AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23932756 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication training intervention (5As: Ask, Advise, Agree, Assist, Arrange)
Number of subjects: 326
Study 23932756 — intervention group
Group type: COMPARATOR
Intervention: Control group (delayed communication training, 8 months later)
Number of subjects: 326
Study 21112668 — intervention group
Group type: EXPERIMENTAL
Intervention: eDerm online curriculum after clerkship
Number of subjects: 252
Study 21112668 — intervention group
Group type: EXPERIMENTAL
Intervention: eDerm online curriculum
Number of subjects: 252
Study 21112668 — intervention group
Group type: COMPARATOR
Intervention: Clerkship
Number of subjects: 252
Study 19733859 — intervention group
Group type: EXPERIMENTAL
Intervention: Apical pacing
Number of subjects: 19
Study 19733859 — intervention group
Group type: COMPARATOR
Intervention: Septal pacing
Number of subjects: 19
Study 16759322 — intervention group
Group type: EXPERIMENTAL
Intervention: Articaine 4% with 1 : 200 000 epinephrine
Number of subjects: 62
Study 16759322 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 2% with 1 : 100 000 epinephrine
Number of subjects: 62
Study 15223191 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral prefrontal leukotomy (LSP)
Number of subjects: 12
Study 15223191 — intervention group
Group type: COMPARATOR
Intervention: Non-leukotomized schizophrenia patients (NLSP)
Number of subjects: 12
Study 15223191 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 12
Study 12501898 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (1-11 tablets, vaginal route)
Number of subjects: 103
Study 9831367 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha + Talpha1 (1 mg twice weekly)
Number of subjects: 34
Study 9831367 — intervention group
Group type: COMPARATOR
Intervention: IFN-alpha alone (3 million units three times a week)
Number of subjects: 34
Study 7716590 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 500 mg every 8 hours
Number of subjects: 377
Study 7716590 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin 500 mg every 6 hours
Number of subjects: 377
Study 2758765 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 2758765 — intervention group
Group type: COMPARATOR
Intervention: Collagen
Number of subjects: 0
Study 2758765 — intervention group
Group type: COMPARATOR
Intervention: PAF
Number of subjects: 0
Study 788079 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous plasminogen
Number of subjects: 500
Study 788079 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 30884961 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioral therapy (CBT)
Number of subjects: 109
Study 30884961 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person cognitive behavioral therapy (CBT)
Number of subjects: 109
Study 31102382 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG) for 12 weeks
Number of subjects: 102
Study 31102382 — intervention group
Group type: COMPARATOR
Intervention: Lactulose for 12 weeks
Number of subjects: 102
Study 31102382 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 102
Study 31102382 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene Glycol (PEG)
Number of subjects: 102
Study 27900529 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior enamel etch + ER adhesive (XP Bond)
Number of subjects: 57
Study 27900529 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior enamel etch + SE adhesive (Clearfil SE Bond)
Number of subjects: 57
Study 27900529 — intervention group
Group type: COMPARATOR
Intervention: Conventional acid-etch sealant (control group)
Number of subjects: 57
Study 27900529 — intervention group
Group type: EXPERIMENTAL
Intervention: SE adhesive (Clearfil SE Bond) without prior etching
Number of subjects: 57
Study 25367184 — intervention group
Group type: EXPERIMENTAL
Intervention: Limberg flap (n=51)
Number of subjects: 102
Study 25367184 — intervention group
Group type: COMPARATOR
Intervention: Excision only (n=51)
Number of subjects: 102
Study 23902780 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with virgin olive oil (TMD+VOO)
Number of subjects: 34
Study 23902780 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Mediterranean diet supplemented with nuts (TMD+Nuts)
Number of subjects: 34
Study 23902780 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet (Control)
Number of subjects: 34
Study 21666588 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin, 2 ml/kg/day, intravenously for 5 days
Number of subjects: 120
Study 21666588 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment without cytoflavin
Number of subjects: 120
Study 19299322 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginkgo biloba 120 mg twice daily for 12 days
Number of subjects: 14
Study 19299322 — intervention group
Group type: COMPARATOR
Intervention: Voriconazole 200 mg alone
Number of subjects: 14
Study 16886840 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (10mg/day for 2 weeks)
Number of subjects: 19
Study 16886840 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15337631 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 452
Study 15337631 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 452
Study 11565630 — intervention group
Group type: EXPERIMENTAL
Intervention: Pagoclone 0.1 mg t.d.s.
Number of subjects: 14
Study 11565630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 9137213 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone, 300 mg/day
Number of subjects: 516
Study 9137213 — intervention group
Group type: COMPARATOR
Intervention: Nonantiarrhythmic therapy
Number of subjects: 516
Study 8205301 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 50
Study 8205301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 3251503 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 41
Study 3251503 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 41
Study 3251503 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.50 mg
Number of subjects: 41
Study 3251503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 30818782 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/day iron (800 mg of iron protein succinylate)
Number of subjects: 18
Study 30818782 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18
Study 27864718 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 NaP tablets
Number of subjects: 461
Study 27864718 — intervention group
Group type: COMPARATOR
Intervention: 4 L of PEG
Number of subjects: 461
Study 25264121 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum-based medium
Number of subjects: 7
Study 25264121 — intervention group
Group type: COMPARATOR
Intervention: Synthetic medium
Number of subjects: 7
Study 23727761 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance/movement therapy
Number of subjects: 115
Study 21252253 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 g/kg fructose in divided oral doses over 6 h (protocol 1)
Number of subjects: 30
Study 21252253 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g/kg fructose, 0.5 g/kg fructose plus 0.5 g/kg glucose, or 1 g/kg fructose plus 1 g/kg glucose (protocol 2)
Number of subjects: 30
Study 19149838 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based exercise (WE)
Number of subjects: 50
Study 19149838 — intervention group
Group type: COMPARATOR
Intervention: Walking on land (WL)
Number of subjects: 50
Study 16936102 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Prognosis (MP) index
Number of subjects: 0
Study 16936102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraocular pressure (IOP) asymmetry
Number of subjects: 0
Study 16936102 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold asymmetry between eyes
Number of subjects: 0
Study 12805326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years (n = 943)
Number of subjects: 1901
Study 12805326 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen for 2 years (n = 958)
Number of subjects: 1901
Study 12805326 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen for 5 years (n = 943) in ER-positive patients
Number of subjects: 1901
Study 11015108 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder-drainage with induction immunotherapy
Number of subjects: 100
Study 11015108 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric-drainage with induction immunotherapy
Number of subjects: 100
Study 11015108 — intervention group
Group type: COMPARATOR
Intervention: Enteric-drainage without induction immunotherapy
Number of subjects: 100
Study 11015108 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladder-drainage
Number of subjects: 100
Study 11015108 — intervention group
Group type: COMPARATOR
Intervention: Enteric-drainage
Number of subjects: 100
Study 8851402 — intervention group
Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 75
Study 8851402 — intervention group
Group type: COMPARATOR
Intervention: Sonography
Number of subjects: 75
Study 1508401 — intervention group
Group type: EXPERIMENTAL
Intervention: ACSF with 50 mM K+ (depolarization)
Number of subjects: 8
Study 1508401 — intervention group
Group type: EXPERIMENTAL
Intervention: ACSF with 50 mM K+, 0 mM Ca2+ and 4 mM Mg2+ (depolarization during blocked synaptic transmission)
Number of subjects: 8
Study 1508401 — intervention group
Group type: COMPARATOR
Intervention: Regular ACSF (control)
Number of subjects: 8
Study 6323338 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 33
Study 6323338 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 33
Study 30289769 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous video EEG monitoring and real-time seizure detection
Number of subjects: 260
Study 30289769 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated neonatal seizure detector algorithm by Persyst
Number of subjects: 260
Study 30289769 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG technician review by Corticare
Number of subjects: 260
Study 29513852 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacille Calmette-Guérin (BCG) revaccination
Number of subjects: 0
Study 29513852 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 26997110 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone completion of the SRS‐22r
Number of subjects: 49
Study 26997110 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone completion of the ODI
Number of subjects: 49
Study 26997110 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone administration preference
Number of subjects: 49
Study 24993757 — intervention group
Group type: EXPERIMENTAL
Intervention: disconnect‐reconnect technique
Number of subjects: 16
Study 24993757 — intervention group
Group type: COMPARATOR
Intervention: push‐pull technique
Number of subjects: 16
Study 24993757 — intervention group
Group type: EXPERIMENTAL
Intervention: both techniques
Number of subjects: 16
Study 22443183 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg daily)
Number of subjects: 140
Study 22443183 — intervention group
Group type: COMPARATOR
Intervention: Insulin dose increase (≥ 10% at week 12 and ≥ 10% at week 24)
Number of subjects: 140
Study 20139217 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed use of antibiotics
Number of subjects: 21
Study 20139217 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic delay strategy
Number of subjects: 21
Study 20139217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle habits and behaviours
Number of subjects: 21
Study 17911711 — intervention group
Group type: EXPERIMENTAL
Intervention: Surveillance system for chronic diseases (intervention group)
Number of subjects: 865
Study 17911711 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 865
Study 11333850 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene dissolved in oil (80 microg per capsule) consumed 2 capsules/day, 7 days/week for up to 10 weeks
Number of subjects: 35
Study 9407423 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 89
Study 9407423 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 89
Study 8501186 — intervention group
Group type: EXPERIMENTAL
Intervention: Homologous intra-uterine insemination with ovulation induction
Number of subjects: 84
Study 8501186 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed natural intercourse with ovulation induction
Number of subjects: 84
Study 8501186 — intervention group
Group type: COMPARATOR
Intervention: Control group (timed homologous intravaginal artificial insemination)
Number of subjects: 84
Study 8501186 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes of pregnancies in the ovulation induced group
Number of subjects: 84
Study 2894890 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 to 40 mg once daily
Number of subjects: 180
Study 2894890 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 to 100 mg once daily
Number of subjects: 180
Study 30239426 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 2629
Study 28705697 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepping Up intervention group
Number of subjects: 266
Study 28705697 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 266
Study 25832289 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative rosuvastatin
Number of subjects: 550
Study 25832289 — intervention group
Group type: COMPARATOR
Intervention: Control (no preoperative rosuvastatin)
Number of subjects: 550
Study 24284249 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib sodium 20/40 mg administered via intravenous injection after admission with 12 hours intervals for six times
Number of subjects: 80
Study 24284249 — intervention group
Group type: COMPARATOR
Intervention: Morphine 2/4 mg initially, additional morphine 2 mg as needed
Number of subjects: 80
Study 20608798 — intervention group
Group type: EXPERIMENTAL
Intervention: Music during non-stress test (NST)
Number of subjects: 201
Study 20608798 — intervention group
Group type: COMPARATOR
Intervention: No music during non-stress test (NST)
Number of subjects: 201
Study 18297254 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril (5 mg)
Number of subjects: 38
Study 18297254 — intervention group
Group type: EXPERIMENTAL
Intervention: atenolol (50 mg)
Number of subjects: 38
Study 17139640 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet‐based physical activity program with individual guidance, a bicycle ergometer, and group contacts (individualized training [IT] group; n = 82)
Number of subjects: 160
Study 17139640 — intervention group
Group type: COMPARATOR
Intervention: Internet‐based program providing only general information on exercises and physical activity (general training [GT] group; n = 78)
Number of subjects: 160
Study 12681027 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg three times daily
Number of subjects: 376
Study 12681027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 376
Study 10924972 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated fractionation (AF) of 30 Gy in 10 daily fractions
Number of subjects: 445
Study 10924972 — intervention group
Group type: COMPARATOR
Intervention: Accelerated hyperfractionated (AH) radiotherapy (1.6 Gy b.i.d. to a total dose of 54.4 Gy)
Number of subjects: 445
Study 10924972 — intervention group
Group type: EXPERIMENTAL
Intervention: MMSE improvement over time
Number of subjects: 445
Study 10924972 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MMSE
Number of subjects: 445
Study 8953351 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data collection regarding experiences of chronic pain
Number of subjects: 75
Study 8953351 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief and validation of pain by others
Number of subjects: 75
Study 8953351 — intervention group
Group type: EXPERIMENTAL
Intervention: Support from health care professionals
Number of subjects: 75
Study 1423948 — intervention group
Group type: EXPERIMENTAL
Intervention: 12,500 IU heparin s.c.
Number of subjects: 0
Study 29843756 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid-based cytology
Number of subjects: 10
Study 29843756 — intervention group
Group type: COMPARATOR
Intervention: Conventional glass slides
Number of subjects: 10
Study 27881082 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing using the cobas 4800 HPV Test across four laboratories (three implementation laboratories and one reference laboratory)
Number of subjects: 500
Study 27881082 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing for negative cytology specimens
Number of subjects: 500
Study 27881082 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV testing for abnormal cytology specimens
Number of subjects: 500
Study 24154666 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline treatment (up to 200 mg/d over 10 weeks)
Number of subjects: 346
Study 23363675 — intervention group
Group type: EXPERIMENTAL
Intervention: Prospective electrocardiography gated group (Group A, 50 cases)
Number of subjects: 96
Study 23363675 — intervention group
Group type: COMPARATOR
Intervention: Prospectively ECG‐triggered high‐pitch spiral mode group (Group B, 46 cases)
Number of subjects: 96
Study 20458104 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical activity program (DeLLITE)
Number of subjects: 193
Study 20458104 — intervention group
Group type: COMPARATOR
Intervention: Social visits (control)
Number of subjects: 193
Study 18211496 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antimycotic treatment
Number of subjects: 0
Study 16983120 — intervention group
Group type: EXPERIMENTAL
Intervention: Two short consolidation cycles
Number of subjects: 473
Study 16983120 — intervention group
Group type: COMPARATOR
Intervention: Berlin‐Frankfurt‐Muenster (BFM) ‐type biphasic 6‐week consolidation
Number of subjects: 473
Study 16983120 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G‐CSF)
Number of subjects: 473
Study 16983120 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensification of induction therapy with HAM (high-dose cytarabine and mitoxantrone)
Number of subjects: 473
Study 16983120 — intervention group
Group type: COMPARATOR
Intervention: Standard induction therapy without HAM
Number of subjects: 473
Study 16983120 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial AML-BFM 98
Number of subjects: 473
Study 12698153 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A
Number of subjects: 74
Study 12698153 — intervention group
Group type: COMPARATOR
Intervention: Tacrolimus
Number of subjects: 74
Study 11020031 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron 8 mg/day
Number of subjects: 16
Study 11020031 — intervention group
Group type: COMPARATOR
Intervention: propranolol 80 mg/day
Number of subjects: 16
Study 11020031 — intervention group
Group type: EXPERIMENTAL
Intervention: both groups
Number of subjects: 16
Study 8736471 — intervention group
Group type: EXPERIMENTAL
Intervention: Orem-based nursing intervention
Number of subjects: 104
Study 8736471 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 1569652 — intervention group
Group type: COMPARATOR
Intervention: 0 mg ascorbic acid (placebo)
Number of subjects: 15
Study 1569652 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg ascorbic acid
Number of subjects: 15
Study 1569652 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg ascorbic acid
Number of subjects: 15
Study 1569652 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 mg ascorbic acid
Number of subjects: 15
Study 1569652 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,000 mg ascorbic acid
Number of subjects: 15
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: SPH (PAS plus isoniazid daily for 18 months with streptomycin for the first three months)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: PH (PAS plus isoniazid daily for 18 months without streptomycin)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: IP (inpatient rest in bed for six months followed by outpatient treatment)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: OP (ambulatory outpatient treatment from the start)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: J (outpatient treatment with a plaster-of-Paris jacket for nine months)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: No J (ambulatory treatment without any support)
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional chemotherapy and/or operation
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall patient outcomes
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional chemotherapy and/or surgery
Number of subjects: 283
Study 2857181 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term outcomes
Number of subjects: 283
Study 30864748 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained BP control at 100% of visits
Number of subjects: 24309
Study 30864748 — intervention group
Group type: COMPARATOR
Intervention: Sustained BP control at <50% of visits
Number of subjects: 24309
Study 29704010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (IP) after NACT and IDS
Number of subjects: 215
Study 29704010 — intervention group
Group type: COMPARATOR
Intervention: Intravenous chemotherapy (IV) after NACT and IDS
Number of subjects: 215
Study 29704010 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (IP) after PDS
Number of subjects: 215
Study 29704010 — intervention group
Group type: COMPARATOR
Intervention: Intravenous chemotherapy (IV) after PDS
Number of subjects: 215
Study 27339796 — intervention group
Group type: EXPERIMENTAL
Intervention: Books/Pamphlets
Number of subjects: 82
Study 27339796 — intervention group
Group type: EXPERIMENTAL
Intervention: Television
Number of subjects: 82